Valin Technologies

Drug Innovation • Biosimilars • Unmet Markets

Our team has extensive experience in the development of biopharmaceuticals

We develop innovative drug therapeutics for markets with unmet needs and with high business potential

About Valin Technologies

Valin Ltd. is a Biotechnology Company focused on research and development (R&D) of innovative biological therapeutics and of biosimilars. Our core competency lays in biopharmaceuticals development throughout the entire drug development value chain. We have extensive experience, from early discovery stages, through complete process development, CMC, pre-clinical and clinical development to approval. We develop drugs for markets with unmet needs and high business potential

Development Pipeline

Valin’s core competency lays in biopharmaceuticals development, throughout the entire drug development value chain. The company focuses on development of innovative drugs and of biosimilars, for markets with unmet needs and high business potential

Our Team

Dr. Marian Gorecki
Dr. Marian Gorecki
Co-founder & Executive director

Dr. Gorecki is a co-founder and serves as CSO and member of the board. With over 35 years in the biotech industry as senior management and entrepreneur, overseeing the approval and marketing of several biologics he brings a rare set of skills and experience

 

Dr. Jacob Hartman
Dr. Jacob Hartman
VP R&D

Dr. Hartman serves as VP R&D. Hartman has over 30 years of experience in R&D of recombinant proteins and has managed teams of R&D through the laborious process of drug development

Dr. Shmulik Hess
Dr. Shmulik Hess
CEO

Dr. Hess serves as CEO. Has over 15 years of experience as a pharmacologist, as an entrepreneur, and in business and operations of biologics and drug development, Dr. Hess has successfully navigated Valin Technologies to its current stage

Mr. Saul Mashaal
Mr. Saul Mashaal
Co-founder & executive director

Mr. Mashaal is a co-founder and executive member, with over 40 years of success in the biopharmaceutical business. Mr. Mashaal has been a successful entrepreneur and CEO of public listed companies. Mr. Mashaal brings vast business experience to Valin

Mr. Yehuda Zelig
Mr. Yehuda Zelig
Co-founder & executive director

Mr. Zelig is a co-founder and serves as a executive member on the board. With over 30 years of experience in development, up-scaling and manufacturing of biologics, holding senior positions in the biotechnology industry Mr. Zelig brings a unique set of skills and knowledge to Valin Technologies

R&D Facility

Valin Technologies has a 1000 m2 state of the art R&D facility for biopharmaceuticals, located in Yavne, Israel

Our Partners

Valin focuses in business partners in emerging markets – tap unmet market needs and business opportunities

A 16,000 m2 biologics manufacturing facility in Anhui province, China

A 10,000 m2 biologics manufacturing facility in the MENA region

A 5000 m2 R&D laboratory facility and GMP mini pilot facility in Sichuan province, China

News & Events: Jan 2017

Anhui (China) economy persons of the year 2016 award

News & Events: Jan 2017

News & Events: Oct 2016

CFDA, the China Food and Drug Administration visit to Israel

News & Events: Oct 2016

News & Events: Jan 2016

NVSI, the National Vaccine and Serum Institute, visit to Valin

News & Events: Jan 2016

News & Events: Sep 2015

Valin-NVSI IL-17RA co-development agreement signature

News & Events: Sep 2015

News & Events: May 2015

Sinopharm, the China National Pharmaceutical Group Corporation, chairman and senior management visit to Valin

News & Events: May 2015

News & Events: Sep 2014

The 2014 China’s Friendship Award to Dr. Shmulik Hess, for experts’ outstanding contribution in economic and social development; the nation’s highest honor for achievement by a foreigner. Read more > 

News & Events: Sep 2014

News & Events: Mar 2014

Valin-HTBT, the Hefei Tianmai Biotechnology Development Corporation, round table on insulin technology

News & Events: Mar 2014

News & Events: May 2013

The 2013 Anhui distinguished Foreign Expert Award to Dr. Shmulik Hess

News & Events: May 2013

Contact Us